Error: Could not add to watchlist. X

FIM Rohto BioMed

+ Watchlist
FIMROHA:FH
17.33
EUR
0.00
0.00%
As of 01:59:30 ET on 08/27/2015.
Fund Type
Open-End Fund
52Wk Range
12.50 - 19.07
1 Yr Return
34.76%
YTD Return
17.33%
Previous Close
17.33
52Wk Range
12.50 - 19.07
1 Yr Return
34.76%
YTD Return
17.33%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 08/27/2015)
17.33
Total Assets (m EUR) (on 07/31/2015)
46.545
Inception Date
05/08/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
TAPANI KOSKENKARI
Front Load Fee
1.00%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.70%
Expense Ratio
1.81%
Top Fund Holdings
Name Position Value % of Fund
Pfizer Inc 127.00 k 4.15 m 8.91
GlaxoSmithKline PLC 140.00 k 2.76 m 5.93
Merck & Co Inc 48.00 k 2.56 m 5.51
Johnson & Johnson 25.50 k 2.31 m 4.97
Roche Holding AG 7.50 k 1.97 m 4.24
Gilead Sciences Inc 17.50 k 1.87 m 4.01
Allergan plc 6.00 k 1.80 m 3.87
Teva Pharmaceutical Industries 27.00 k 1.69 m 3.63
Meda AB 100.00 k 1.49 m 3.19
Biogen Inc 5.00 k 1.44 m 3.10
Profile
FIM Rohto BioMed is an open-end fund registered in Finland. The Fund's objective is long-term capital appreciation. The Fund invests in shares, and share-related securities of companies operating in the pharmaceuticals sector as well as the biotechnology, food technology and helathcare technology sectors. Emphasis is put on listed European and North American companies.
ADDRESS
Pohjoisesplanadi 33 A
00100 Helsinki
Finland
PHONE
358-9-6134-6380